Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Mednax Center for Research, Education and Quality
ClinicalTrials.gov Identifier:
NCT01708707
First received: April 25, 2012
Last updated: March 29, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: June 2017
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)